Raymond James Financial Inc Intellia Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 411,077 shares of NTLA stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
411,077Holding current value
$4.16 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
321Shares Held
91.4MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$127 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$97.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$97.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$52.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$50.1 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $770M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...